Propentofylline protects β-amyloid protein-induced apoptosis in cultured rat hippocampal neurons

European Journal of Pharmacology

Volumn 458, Issue 3, 2003, Pages 235-241

  Koriyama, Yoshiki ^a,b   Chiba, Kenzo ^a   Mohri, Tetsuro ^a  

^a HOKURIKU UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Amyloid protein; Apoptosis; cAMP; Hippocampal neuron; Propentofylline; Protein kinase A

Indexed keywords

AMYLOID BETA PROTEIN; BUCLADESINE; CASPASE 3; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROPENTOFYLLINE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; FETUS; HIPPOCAMPUS; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASES; CELL SURVIVAL; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; HIPPOCAMPUS; ISOQUINOLINES; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; SULFONAMIDES; XANTHINES;

EID: 0037419533     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02789-9     Document Type: Article

References (39)

1. Andine P., Rudolphi K.A., Fredholm B.B., Hagberg H. Effect of propentofylline (HWA 285) on extracellular purines and excitatory amino acids in CA1 of rat hippocampus during transient ischaemia. Br. J. Pharmacol. 100:1990;814-818.
2. Banati R.B., Schubert P., Rothe G., Gehrmann J., Rudolphi K., Valet G., Kreutzberg G.W. Modulation of intracellular formation of reactive oxygen intermediates in peritoneal macrophages and microglia/brain macrophages by propentofylline. J. Cereb. Blood Flow Metab. 14:1994;145-149.
3. Bayatti N., Engele J. Cyclic AMP modulates the response of central nervous system glia to fibroblast growth factor-2 by redirecting signalling pathways. J. Neurochem. 78:2001;972-980.
4. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 77:1994;817-827.
5. Cotman C.W., Anderson A.J. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10:1995;19-45.
6. DeLeo J., Schubert P., Kreutzberg G.W. Propentofylline (HWA 285) protects hippocampal neurons of Mongolian gerbils against ischemic damage in the presence of an adenosine antagonist. Neurosci. Lett. 84:1988;307-311.
7. Desire L., Courtois Y., Jeanny J.C. Endogenous and exogenous fibroblast growth factor 2 support survival of chick retinal neurons by control of neuronal bcl-x(L) and bcl-2 expression through a fibroblast growth factor receptor 1- and ERK-dependent pathway. J. Neurochem. 75:2000;151-163.
8. Estus S., Tucker H.M., van-Rooyen C., Wright S., Brigham E.F., Wogulis M., Rydel R.E. Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant "apoptotic" pattern of gene induction. J. Neurosci. 17:1997;7736-7745.
9. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., Angeretti N. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. NeuroReport. 4:1993;523-526.
10. Fredholm B.B., Fastbom J., Kvanta A., Gerwins P., Parkinson F. Further evidence that propentofylline(HWA 285) influences both adenosine receptors and adenosine transport. Fundam. Clin. Pharmacol. 6:1992;99-111.
11. Gschwind M., Huber G. Apoptotic cell death induced by beta-amyloid 1-42 peptide is cell type dependent. J. Neurochem. 65:1995;292-300.
12. Guo Q., Sebastian L., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., Mattson M.P. Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation. J. Neurochem. 72:1999;1019-1029.
13. Harada H., Becknell B., Wilm M., Mann M., Huang L.J., Taylor S.S., Scott J.D., Korsmeyer S.J. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell. 3:1999;413-422.
14. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron. 13:1994;45-53.
15. Kitamura Y., Taniguchi T., Shimohama S. Apoptotic cell death in neurons and glial cells: implications for Alzheimer's disease. Jpn. J. Pharmacol. 79:1999;1-5.
16. Kobayashi Y., Shinozawa T. Effect of dibutyryl cAMP and several reagents on apoptosis in PC12 cells induced by a sialoglycopeptide from bovine brain. Brain Res. 778:1997;309-317.
17. Koriyama Y., Yamazaki M., Chiba K., Mohri T. Evaluation of neurotoxicity of Alzheimer's amyloid beta protein (beta42) in cultured hippocampal cells and its prevention by propentofylline. Jpn. J. Pharmacol. 82:2000;301-306.
18. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U. S. A. 90:1993;7951-7955.
19. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
20. Marcusson J., Rother M., Kittner B., Rossner M., Smith R.J., Babic T., Folnegovic-Smalc V., Moller H.J., Labs K.H. A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group. Dement. Geriatr. Cogn. Disord. 8:1997;320-328.
21. Matsuzawa A., Ichijo H. Molecular mechanisms of the decision between life and death: regulation of apoptosis by apoptosis signal-regulating kinase 1. J. Biochem. 130:2001;1-8.
22. Meskini N., Nemoz G., Okyayuz-Baklouti I., Lagarde M., Prigent A.F. Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. Biochem. Pharmacol. 47:1994;781-788.
23. Moran J., Itoh T., Reddy U.R., Chen M., Alnemri E.S., Pleasure D. Caspase-3 expression by cerebellar granule neurons is regulated by calcium and cyclic AMP. J. Neurochem. 73:1999;568-577.
24. Nagata K., Ogawa T., Omosu M., Fujimoto K., Hayashi S. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity. Arzneimittel-Forschung. 35:1985;1034-1036.
25. Ohkubo T., Mitsumoto Y., Mohri T. Characterization of the uptake of adenosine by cultured rat hippocampal cells and inhibition of the uptake by xanthine derivatives. Neurosci. Lett. 13:1991;275-278.
26. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
27. Park C.K., Rudolphi K.A. Antiischemic effects of propentofylline (HWA 285) against focal cerebral infarction in rats. Neurosci. Lett. 178:1994;235-238.
28. Parvathenani L.K., Calandra V., Roberts S.B., Posmantur R. cAMP delays beta-amyloid (25-35) induced cell death in rat cortical neurons. NeuroReport. 11:2000;2293-2297.
29. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
30. Prehn J.H., Bindokas V.P., Jordan J., Galindo M.F., Ghadge G.D., Roos R.P., Boise L.H., Thompson C.B., Krajewski S., Reed J.C., Miller R.J. Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol. Pharmacol. 49:1996;319-328.
31. Pugazhenthi S., Miller E., Sable C., Young P., Heidenreich K.A., Boxer L.M., Reusch J.E. Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein. J. Biol. Chem. 274:1999;27529-27535.
32. Saletu B., Moller H.J., Grunberger J., Deutsch H., Rossner M. Propentofylline in adult-onset cognitive disorders: double-blind, placebo-controlled, clinical, psychometric and brain mapping studies. Neuropsychobiology. 24:1990;173-184.
33. Schubert P., Rudolphi K.A., Fredholm B.B., Nakamura Y. Modulation of nerve and glial function by adenosine - role in the development of ischemic damage. Int. J. Biochem. 26:1994;1227-1236.
34. Shinoda I., Furukawa Y., Furukawa S. Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cells. Biochem. Pharmacol. 39:1990;1813-1816.
35. Takadera T., Sakura N., Mohri T., Hashimoto T. Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention. Neurosci. Lett. 161:1993;41-44.
36. Tamaoka A., Odaka A., Ishibashi Y., Usami M., Sahara N., Suzuki N., Nukina N., Mizusawa H., Shoji S., Kanazawa I., Mori H. APP717 missense mutation affects the ratio of amyloid beta protein species(Abeta1-42/43 and Abeta1-40) in familial Alzheimer's disease brain. J. Biol. Chem. 269:1994;32721-32724.
37. Tong L., Thornton P.L., Balazs R., Cotman C.W. Beta-amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised. J. Biol. Chem. 276:2001;17301-17306.
38. Yamada K., Tanaka T., Senzaki K., Kameyama T., Nabeshima T. Propentofylline improves learning and memory deficits in rats induced by beta-amyloid protein-(1-40). Eur. J. Pharmacol. 349:1998;15-22.
39. Yin X.M., Oltvai Z.N., Korsmeyer S.J. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 369:1994;321-323.